Gw&K Investment Management, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Gw&K Investment Management, LLC
- $11.7 Billion
- Q3 2024
A detailed history of Gw&K Investment Management, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 732,892 shares of CRNX stock, worth $37.1 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
732,892
Previous 377,663
94.06%
Holding current value
$37.1 Million
Previous $16.9 Million
121.39%
% of portfolio
0.32%
Previous 0.15%
Shares
7 transactions
Others Institutions Holding CRNX
# of Institutions
241Shares Held
79.5MCall Options Held
23.3KPut Options Held
44.3K-
Vanguard Group Inc Valley Forge, PA6.29MShares$319 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$316 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.89MShares$298 Million2.95% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.94MShares$251 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA4.46MShares$226 Million0.04% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.72B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...